HFI-shielded islets grown well within the spleen. HFI-shielded islets displayed a round shape and well-preserved surface contour resembling pancreatic islets within the spleen. Confocal 3D imaging of ...

Model more closely replicates natural environment of the pancreas, which will be essential for studying diabetes and ...

Additionally, when functional pancreatic cells die, particularly acinar cells ... whereas its accumulation in the islets of Langerhans, which produce insulin and glucagon, is associated with ...

In the pancreas, islets are grouped within lobules ... Abundance was calculated as the number of cells assigned to the given CN divided by the number of acinar cells. Significance was determined using ...

In an effort to reduce the ratio of presumably noncontributing acinar tissue to islet tissue specimens were obtained that demonstrated atrophy of the pancreatic acini in dogs two months after ...

the acini and ducts of the exocrine pancreas and the endocrine islets of Langerhans. Acinar cells release enzymes that help break down food, while ductal cells form channels to carry the enzymes ...

Cancer of the acinar cells The acinar cells are at the ends ... are made and released into the bloodstream. They are also called pancreatic neuroendocrine tumours (PNETS) or islet cell tumours. These ...

Islet-cell carcinomas of the alpha-cell type ... carbohydrate metabolism associated with adenocarcinoma of the acinar pancreas and other advanced neoplastic disease. However, a lack of or ...

The functions of acinar and beta-cells are very distinct ... is that our cells actually infiltrated pre-existing pancreatic islets, where beta cells normally reside," said Esni.

today announced that Science Translational Medicine has published a paper titled “Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic ...

When this occurs, it is called acinar cell carcinoma ... Also known as endocrine or islet cell tumors, neuroendocrine cancers are rare, making up less than 5 percent of all pancreatic cancer cases.